Anna Strongin

419 total citations
8 papers, 290 citations indexed

About

Anna Strongin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Anna Strongin has authored 8 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Anna Strongin's work include Pancreatic and Hepatic Oncology Research (3 papers), Gallbladder and Bile Duct Disorders (2 papers) and Pancreatitis Pathology and Treatment (2 papers). Anna Strongin is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Gallbladder and Bile Duct Disorders (2 papers) and Pancreatitis Pathology and Treatment (2 papers). Anna Strongin collaborates with scholars based in United States and Lebanon. Anna Strongin's co-authors include Harkirat Singh, David E. Loren, Thomas E. Kowalski, Ali A. Siddiqui, Scott E. Strome, R. Taylor, William F. Regine, Mohan Suntharalingam, Jeffrey S. Wolf and Ann B. Zimrin and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Gastrointestinal Endoscopy and Digestive Diseases and Sciences.

In The Last Decade

Anna Strongin

7 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Strongin United States 7 202 115 89 66 44 8 290
H Iro Germany 8 141 0.7× 161 1.4× 60 0.7× 157 2.4× 75 1.7× 28 316
Mamoru Miyaguchi Japan 11 162 0.8× 150 1.3× 76 0.9× 117 1.8× 26 0.6× 33 319
Whee-Sze Ong Singapore 5 144 0.7× 274 2.4× 98 1.1× 200 3.0× 92 2.1× 6 417
Micah Ellison United Kingdom 2 129 0.6× 112 1.0× 52 0.6× 220 3.3× 14 0.3× 2 350
Maria Laura Rubin United States 9 96 0.5× 260 2.3× 81 0.9× 87 1.3× 64 1.5× 10 363
Gregory Vlacich United States 10 133 0.7× 89 0.8× 152 1.7× 78 1.2× 24 0.5× 23 324
D. Spielsinger United States 5 76 0.4× 268 2.3× 125 1.4× 91 1.4× 96 2.2× 11 352
Margarita Escrig United States 5 232 1.1× 323 2.8× 140 1.6× 45 0.7× 52 1.2× 5 529
Hans Stoop Netherlands 10 276 1.4× 95 0.8× 166 1.9× 6 0.1× 31 0.7× 15 399

Countries citing papers authored by Anna Strongin

Since Specialization
Citations

This map shows the geographic impact of Anna Strongin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Strongin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Strongin more than expected).

Fields of papers citing papers by Anna Strongin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Strongin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Strongin. The network helps show where Anna Strongin may publish in the future.

Co-authorship network of co-authors of Anna Strongin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Strongin. A scholar is included among the top collaborators of Anna Strongin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Strongin. Anna Strongin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kamal, Natasha, Beatriz E. Marciano, Anna Strongin, et al.. (2020). The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease. Gastroenterology report. 8(5). 404–406. 12 indexed citations
2.
Arora, Manish, Anna Strongin, Jennifer Heimall, et al.. (2017). Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome. Journal of Clinical Immunology. 37(7). 695–700. 49 indexed citations
3.
Strongin, Anna, Theo Heller, Dan Doherty, et al.. (2017). Characteristics of Liver Disease in 100 Individuals With Joubert Syndrome Prospectively Evaluated at a Single Center. Journal of Pediatric Gastroenterology and Nutrition. 66(3). 428–435. 17 indexed citations
4.
Siddiqui, Ali A., Jeffrey J. Easler, Anna Strongin, et al.. (2013). Hydrogen Peroxide-Assisted Endoscopic Necrosectomy for Walled-Off Pancreatic Necrosis: A Dual Center Pilot Experience. Digestive Diseases and Sciences. 59(3). 687–690. 40 indexed citations
5.
Strongin, Anna, et al.. (2013). Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinoma. Endoscopic Ultrasound. 2(2). 71–71. 22 indexed citations
6.
Siddiqui, Ali A., John M. DeWitt, Anna Strongin, et al.. (2013). Outcomes of EUS-guided drainage of debris-containing pancreatic pseudocysts by using combined endoprosthesis and a nasocystic drain. Gastrointestinal Endoscopy. 78(4). 589–595. 65 indexed citations
7.
Strongin, Anna, Susannah Yovino, R. Taylor, et al.. (2011). Primary Tumor Volume Is an Important Predictor of Clinical Outcomes Among Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck Treated With Definitive Chemoradiotherapy. International Journal of Radiation Oncology*Biology*Physics. 82(5). 1823–1830. 85 indexed citations
8.
Strongin, Anna, et al.. (2010). [Prognostic value of cardiovascular autonomic neuropathy in patients with combination type 2 diabetes mellitus and chronic heart failure].. PubMed. 50(2). 26–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026